Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma
Luuk van Hooren(Uppsala University), Anna Dimberg(Uppsala University)
Cited by 2
Related Papers
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
|Nature Communications|2021|149